Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2013 · 10-Q
Revenue$4.85B$4.85B−8.3% vs Q1 2012 Net Income$545.00M$545.00M−56.1% vs Q1 2012 EPS Diluted$0.34$0.34−56.4% vs Q1 2012 Gross Profit$2,479,000,000−8.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$460,000,000−79.3% Free Cash Flowderived$186,000,000−89.5% Margins · derivedGross margin51.1%−0.3 pt vs Q1 2012
Operating margin12.7%+3.1 pt vs Q1 2012
Net margin11.2%−12.3 pt vs Q1 2012
ended Mar 31, 2013 · filed May 8, 2013 · 38 d after period end